Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AGTC

Applied Genetic Technologies (AGTC) Stock Price, News & Analysis

Applied Genetic Technologies logo

About Applied Genetic Technologies Stock (NASDAQ:AGTC)

Advanced Chart

Key Stats

Today's Range
$0.39
$0.39
50-Day Range
$0.37
$0.42
52-Week Range
$0.23
$2.83
Volume
N/A
Average Volume
943,490 shs
Market Capitalization
$26.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AGTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied Genetic Technologies and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AGTC Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.tc pixel
Genetic Technologies Limited (GENE)
See More Headlines

AGTC Stock Analysis - Frequently Asked Questions

Applied Genetic Technologies Co. (NASDAQ:AGTC) posted its quarterly earnings data on Tuesday, November, 9th. The biotechnology company reported ($0.40) EPS for the quarter, missing analysts' consensus estimates of ($0.35) by $0.05.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Applied Genetic Technologies investors own include Tesla (TSLA), Meta Platforms (META), NIO (NIO), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD) and Viking Therapeutics (VKTX).

Company Calendar

Last Earnings
11/09/2021
Today
8/30/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:AGTC
CIK
1273636
Fax
N/A
Employees
83
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.46)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$68.94 million
Net Margins
N/A
Pretax Margin
-21,537.54%
Return on Equity
-192.90%
Return on Assets
-92.54%

Debt

Debt-to-Equity Ratio
0.39
Current Ratio
1.40
Quick Ratio
1.40

Sales & Book Value

Annual Sales
$320 thousand
Price / Sales
83.19
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.26 per share
Price / Book
1.51

Miscellaneous

Outstanding Shares
67,632,000
Free Float
64,859,000
Market Cap
$26.62 million
Optionable
Optionable
Beta
1.55

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:AGTC) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners